Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Omnicare Boosts Specialty Pharma Services With $235 Mil. RxCrossroads Buy

This article was originally published in The Pink Sheet Daily

Executive Summary

Acquisition will enable company to leverage "end-to-end" product development through post-commercialization offerings, company says. Omnicare is now in discussions with NeighborCare after raising its takeover bid to $1.55 bil.

You may also be interested in...



Omnicare Continues Acquisition Activity With excelleRx Deal

Purchase of hospice care provider excelleRx is Omnicare’s third acquisition in a week. The firm has no specific plans for further expansion, but will consider opportunities as they are presented.

Omnicare Continues Acquisition Activity With excelleRx Deal

Purchase of hospice care provider excelleRx is Omnicare’s third acquisition in a week. The firm has no specific plans for further expansion, but will consider opportunities as they are presented.

Omnicare And NeighborCare Reach $1.8 Bil. Merger Agreement

NeighborCare agrees to Omnicare's latest offer announced July 5, ending over a year of takeover overtures. The merger is expected to close during the third quarter.

Related Content

Topics

UsernamePublicRestriction

Register

ID1131516

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel